The compound is supplied strictly for laboratory research purposes, and none of this research constitutes clinical evidence of efficacy in humans
Future research could further explore the combination of CUL5-knockout CAR-NK cells with other immunotherapeutics, such as PD-1/PD-L1 inhibitors, to potentially amplify the anti-tumor response
(PubMed) Rahimdel A, Zeinali A, Yazdian-Anari P, Hajizadeh R, Arefnia E
These stressors can disrupt normal metabolic flux, potentially leading to the accumulation of toxic intermediates within cells and altering cellular metabolic homeostasis (21)
Interestingly, the baseline escape latency in older control animals was significantly higher than in young controls, confirming the age-related decline in spatial memory that we'd expect to see
Many providers incorporate it into comprehensive immune-support strategies